Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Fatigue Improvement after Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: Apropos of a Case

Javier Munoz* and Philip Kuriakose

Department of Hematology and Oncology, Henry Ford Hospital, 2799 W, Grand Blvd, Detroit Michigan 48202, USA

Corresponding Author:
Javier Munoz
Department of Hematology and Oncology
Henry Ford Hospital, Hematology-Oncology
2799 West Grand Blvd, Detroit, MI 48202, USA
Tel: 713-792-3934 / 713-854-6211
Fax: 713-792-3983
E-mail: Javier.munoz@me.com

Received Date: May 02, 2012; Accepted Date: June 14, 2012; Published Date: June 18, 2012

Citation:Munoz J, Kuriakose P (2012) Fatigue Improvement after Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: Apropos of a Case. J Palliative Care Med 2:118. doi:10.4172/2165-7386.1000118

Copyright: © 2012 Munoz J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

A 54-year-old male presented with shortness of breath and was diagnosed with pulmonary emboli. Laboratory studies revealed hemolytic anemia. Flow cytometry showed a prominent white blood cell clone without CD59 in 85% (NV 0-3.0) and red blood cells with 8.5% CD59 absence (NV 0-3.0) confirming a diagnosis of paroxysmal nocturnal hemoglobinuria. Eculizumab was started to decrease the possibility of a thrombotic recurrence, with incidentally, a marked subjective improvement of symptomatology, as fatigue, was seen. We reviewed current literature regarding the improvement in fatigue seen in patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab.

Keywords

Recommended Conferences
Google Scholar citation report
Citations : 2035

Journal of Palliative Care & Medicine received 2035 citations as per Google Scholar report

Journal of Palliative Care & Medicine peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page
Top